Finished
Epione® Post-Market Clinical Follow-up Study
NCT05529979 · Quantum Surgical · Updated 6 Jan 2026
- What is being tested
- EPIONE® CT-Guided Percutaneous procedures
- For
- Cancer Abdomen
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years and older. About 55 people. The full rules are on the registry page.
- Where
- France
- When
- Starts or started 28 April 2022, ends 27 April 2024. Registered 7 Sept 2022.
- Results
- Posted on the registry on 6 Jan 2026.
In the researchers' words
Post-Market Clinical Follow-up study in order to consolidate performance and safety data of the EPIONE® device when used for percutaneous procedures in the abdomen
Sites
- Gustave Roussy InstitutVillejuif, France